Giorgio Quadri | Metabolic Therapies and Longevity: Beyond Disease Management | MLS26

*Cardiovascular Outcomes* Can metabolic therapies protect the heart as well as control diabetes? In this session from *Metabolic Therapies and Longevity: Beyond Disease Management* at the *Milan Longevity Summit 2026*, *Dr. Giorgio Quadri* examines one of the most consequential developments in modern metabolic medicine: the cardiovascular effects of therapies originally developed to manage diabetes and obesity. Cardiovascular disease remains one of the major drivers of mortality and reduced healthspan. Understanding whether metabolic treatments can lower cardiovascular risk, prevent major events, and protect patients over the long term has therefore become central to evaluating their true clinical value. Dr. Quadri explores the evidence from cardiovascular outcome studies and what these findings mean for a more integrated approach to metabolic and cardiovascular prevention. Dr. Giorgio Quadri is a Medical Officer at *A.O. Ordine Mauriziano di Torino*, with clinical expertise spanning cardiovascular medicine and the management of patients with complex cardiometabolic risk. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a *One Health* perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. #MilanLongevitySummit #Longevity #OneHealth #GiorgioQuadri #CardiovascularHealth #MetabolicHealth #HeartHealth #Diabetes #Prevention #Healthspan